The Effect of prethrombolytic cyclosporine-a injection on clinical outcome of acute anterior st-elevation myocardial infarction

Cardiovascular Therapeutics

Volumn 31, Issue 4, 2013, Pages

  Ghaffari, Samad ^a   Kazemi, Babak ^a   Toluey, Mehdi ^a   Sepehrvand, Nariman ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cyclosporine A; Myocardial infarction; Preconditioning; Reperfusion injury; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIDOCAINE; LOOP DIURETIC AGENT; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NITRATE; PLACEBO; STREPTOKINASE;

ADULT; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; ENZYME RELEASE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

CYCLOSPORINE-A; MYOCARDIAL INFARCTION; PRECONDITIONING; REPERFUSION INJURY; THROMBOLYSIS;

AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ARRHYTHMIAS, CARDIAC; CHI-SQUARE DISTRIBUTION; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HEART FAILURE; HUMANS; INJECTIONS, INTRAVENOUS; IRAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIUM; PILOT PROJECTS; STROKE VOLUME; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84880663147     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12010     Document Type: Article

References (36)

1. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med 1993;329:1615-1622.
2. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
3. Crompton M, Barksby E, Johnson N, Capano M. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie 2002;84:143-152.
4. Di Lisa F, Bernardi P. Mitochondria and ischemia reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006;70:191-199.
5. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004;61:372-385.
6. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischemia and reperfusion. J Mol Cell Cardiol 2003;35:339-341.
7. Bernardi P, Petronelli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr 1996;28:129-136.
8. Piper HM, Meuter K, Schafer C. Cellular mechanisms of ischemia reperfusion injury. Ann Thorac Surg 2003;75:S644-S6448.
9. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001;276:2571-2575.
10. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005;38:367-374.
11. Gomez L, Thibault H, Gharib A, et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2007;293:H1654-H1661.
12. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischemia-reperfusion injury. Cardiovasc Res 2003;60:617-625.
13. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 2002;55:534-543.
14. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359:473-481.
15. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2004;44:E1-E212.
16. Ghaffari S, Kazemi B, Golzari IG. Efficacy of a New Accelerated Streptokinase Regime in Acute Myocardial Infarction: A Double Blind Randomized Clinical Trial. Cardiovasc Ther 2011. doi:10.1111/j.1755-5922.2011.00284.x. [Epub ahead of print]
17. James TN, Bruschke AV, Böthig S, et al. Report of WHO/ISFC task force on nomenclature of coronary arteriograms. Circulation 1986;74:451A-455A.
18. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993;21:537-545.
19. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
20. Yellon DM, Baxter GF. Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 1999;9:245-249.
21. Karlsson LO, Zhou AX, Larsson E, Aström-Olsson K, Månsson C, Akyürek LM, Grip L. Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Pharmacol Ther 2010;15:182-189.
22. Pagel PS, Krolikowski JG. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits. Anesth Analg 2009;108:1076-1082.
23. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: role of mitochondrial KATP channels. Anesth Analg 2005;101:1590-1596.
24. Dow J, Kloner RA. Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther 2007;12:153-163.
25. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307:93-98.
26. D'Angelo G, Duplan E, Vigne P, Frelin C. Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1alpha Pro-564 hydroxylation. J Biol Chem 2003;278:15406-15411.
27. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 2005;46:2116-2124.
28. Cai Z, Zhong H, Bosch-Marce M, et al. Complete loss of ischemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiol Res 2008;77:463-470.
29. Laudi S, Weimann J, Haschke M, et al. Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine. J Physiol Pharmacol 2007;58:19-32.
30. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
31. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.
32. Iwakura K, Ito H, Kawano S, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001;38:472-477.
33. Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008;117:3152-3156.
34. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004;110:e506-e510.
35. Giugliano RP, Sabatine MS, Gibson CM, et al. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol 2004;93:1362-1367.
36. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008;52:181-189.